Triple Negative Breast Cancer Study Tests Way of Monitoring Metastasis Using Blood Samples
News
Cynvenio Biosystems, Inc. recognized the recent Triple Negative Breast Cancer Day by announcing the launch of a clinical trial in women with triple negative breast cancer (TNBC), a breast cancer subtype marked by negative estrogen-, ... Read more